NemaLife & UC Davis enter into research partnership
NemaLife and UC Davis enter into a research partnership to test the therapeutic potential of several novel psychoplastogens developed in...
top of page
- Apr 7, 2022
Artificial intelligence discovers ingredients for food, supplements
Using AI, companies survey thousands of plant compounds to quickly and automatically identify potential ingredients for use in foods and...
- Apr 1, 2022
New Approaches for Incorporating Genetic Diversity into Toxicity Testing
Our study aims to combine state-of-the art advances in microfluidics, computer vision, laboratory automation and a massively curated...
- Mar 14, 2022
Canopy Growth presents toxicity data of cannabigerol in C. elegans
Canopy Growth Corporation's Vice President of Human & Animal Research, Dr. Marcel Bonn-Miller is giving a talk about the long-term...
- Jan 18, 2022
DEA registered NemaLife Inc. to work with Schedule 2-5 substances
NemaLife Inc., completed its DEA schedule 2-5 registration. If you have scheduled compounds to test reach out to our expert for a free...
- Jul 20, 2021
Innovative Tech Measures Muscle Strength of Worms in Space to Prepare Astronauts for Future Missions
Loss of muscle mass and strength in astronauts remains an issue for space exploration. C. elegans shares common traits with humans and...
- Nov 20, 2020
First research completed on the whole-life toxicity of CBD
Canopy Growth Corporation and its medical division, Spectrum Therapeutics, have completed and published a new study on the long-term...
- Oct 23, 2020
Worm-on-Chip Platform for long term culture and study
A microfluidic platform for long term culture and study of C. elegans Posted at 17:19h in Latest Research by Pouriya Bayat The short life...
- Jun 3, 2020
New Approaches for Incorporating Genetic Diversity into Toxicity Testing
Testing Lifespan/Healthspan-Extension Interventions in the Models of Alzheimer’s Disease (AD/ADRD) (R43/R44 Clinical Trial Not Allowed...
bottom of page